Position in AMGN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$17,423,041
+$654,575 QoQ
Shares Held
48,114
+1.0% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
#410
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 63%
Shared 0%
None 37%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RWA WEALTH PARTNERS, LLC holds $307,753,519 across 11 Drug Manufacturers - General names. AMGN ranks #4 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
387,249 | $98,349,628 | |
| 2 | LLY |
ELI LILLY & Co
|
76,026 | $91,187,872 | |
| 3 | ABBV |
AbbVie Inc.
|
235,826 | $59,343,254 | |
| 4 | AMGN |
Amgen Inc
This page
|
48,114 | $17,423,041 | |
| 5 | MRK |
Merck & Co., Inc.
|
111,388 | $14,313,357 | |
| 6 | AZN |
Astrazeneca PLC
|
45,390 | $8,606,851 | |
| 7 | PFE |
Pfizer Inc
|
285,238 | $6,868,530 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
34,341 | $4,338,641 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,423,041 | 48,114 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $16,768,466 | 47,658 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $15,630,033 | 47,753 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $12,759,108 | 45,213 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $9,667,645 | 34,625 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $10,782,433 | 34,609 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $8,428,836 | 32,339 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $10,689,960 | 33,177 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $10,267,731 | 32,862 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $9,252,056 | 32,541 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $8,174,294 | 28,381 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $5,063,438 | 18,840 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $3,901,779 | 17,574 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $879,486 | 3,638 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $974,131 | 3,709 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $875,904 | 3,886 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $1,014,317 | 4,169 | Shares | Sole | 2022-07-14 | |
| 2022-03-31 | $7,361,968 | 30,444 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $6,361,251 | 28,276 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $6,252,122 | 29,401 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $7,062,412 | 28,974 | Shares | Sole | 2021-07-09 | |
| 2021-03-31 | $7,033,112 | 28,267 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $5,350,698 | 23,272 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $6,048,753 | 23,799 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $5,195,524 | 22,028 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $4,200,362 | 20,719 | Shares | Sole | 2020-04-08 | |
| No filing history on record for this holder in this stock. | ||||||